alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-25-1998
<PERIOD-START>                             DEC-27-1997
<PERIOD-END>                               MAR-28-1998
<CASH>                                           7,409
<SECURITIES>                                     6,140
<RECEIVABLES>                                   69,599
<ALLOWANCES>                                     2,770
<INVENTORY>                                     54,344
<CURRENT-ASSETS>                               161,458
<PP&E>                                         131,328
<DEPRECIATION>                                  66,702
<TOTAL-ASSETS>                                 271,464
<CURRENT-LIABILITIES>                           57,391
<BONDS>                                         50,663
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           113
<OTHER-SE>                                     161,216
<TOTAL-LIABILITY-AND-EQUITY>                   271,464
<SALES>                                         66,507
<TOTAL-REVENUES>                                66,507
<CGS>                                           40,307
<TOTAL-COSTS>                                   40,307
<OTHER-EXPENSES>                                27,574
<LOSS-PROVISION>                                    65
<INTEREST-EXPENSE>                               1,187
<INCOME-PRETAX>                                (1,374)
<INCOME-TAX>                                     (503)
<INCOME-CONTINUING>                              (871)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (871)
<EPS-PRIMARY>                                   (0.09)<F1>
<EPS-DILUTED>                                   (0.09)
<FN>
<F1>For Purposes of This Exhibit, Primary means Basic.
</FN>
        

</TABLE>
Submitted March 7,

sentences in both cases vacated and remanded for resentencing; otherwise affirmed May 14, 2008

#### STATE OF OREGON, *Plaintiff-Respondent, v.*JOHN GRANT BARTLEY, *Defendant-Appellant.*

Clackamas County Circuit Court

CR0501410, CR0600024

A132272 (Control); A132273

184 P3d 1225

Peter Gartlan, Chief Defender, Legal Services Division, and Marc D. Brown, Deputy Public Defender, Office of Public Defense Services, filed the brief for appellant.

Hardy Myers, Attorney General, Mary H. Williams, Solicitor General, and David B. Thompson, Senior Assistant Attorney General, filed the brief for respondent.

Before Landau, Presiding Judge, and Schuman, Judge, and Ortega, Judge.

PER CURIAM

*126PER CURIAM

This is a consolidated appeal involving two criminal cases. In Case Number A132272, defendant pleaded guilty to one count of delivery of a controlled substance. In Case Number A132273, defendant pleaded guilty to one count of delivery of a controlled substance. At sentencing on both cases, defendant’s attorney did not appear because of health problems. Defendant asked for a setover, and the trial court granted the request. The trial court reset the sentencing on two additional occasions, both because of defendant’s counsel’s health problems. At a fourth sentencing hearing, counsel again did not appear because of health problems, and defendant asked for a setover to obtain new counsel. The court granted the request. At a fifth sentencing hearing, counsel did not appear and defendant had not yet retained new counsel. Defendant requested another setover, which the court denied. The court then imposed sentence. Defendant now appeals, arguing that the trial court erred in denying him counsel at the sentencing hearing. The state concedes the error and agrees that the sentences should be vacated and remanded for resentencing. We agree that the trial court erred.

Sentences in both cases vacated and remanded for resentencing; otherwise affirmed.
II 

114TH CONGRESS 

1ST SESSION S. 845 

To require the Secretary of the Treasury to implement security measures 

in the electronic tax return filing process to prevent tax refund fraud 

from being perpetrated with electronic identity theft. 

IN THE SENATE OF THE UNITED STATES 

MARCH 24, 2015 

Mr. RUBIO introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To require the Secretary of the Treasury to implement security measures in the electronic tax return filing process 

to prevent tax refund fraud from being perpetrated with 

electronic identity theft. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. IMPLEMENTATION OF SECURITY MEASURES IN 

4 ELECTRONIC TAX RETURN FILING PROCESS 

5 TO PREVENT TAX REFUND FRAUD. 

6 The Secretary of the Treasury, or the Secretary’s 

7 designee, shall implement security measures in the elec8 tronic tax return filing process designed to prevent tax reVerDate Sep 11 2014 02:14 Mar 31, 2015 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\S845.IS S845

SSpencer on DSK4SPTVN1PROD with BILLS
2 

•S 845 IS

1 fund fraud from being perpetrated through the use of elec2 tronic identity theft. Such measures shall include the use 

3 of security questions which allow for electronic matching 

4 of the answers to such questions to establish the identity 

5 of the taxpayer before the electronic filing of a tax return 

6 by such taxpayer. 

Æ 


SSpencer on DSK4SPTVN1PROD with BILLS
N OTE : This order is nonprecedential. 

# United States Court of Appeals **for the Federal Circuit**

__________________________ HIF BIO, INC. AND BIZBIOTECH CO., LTD., Plaintiffs-Appellees,

v. YUNG SHIN PHARMACEUTICALS INDUSTRIAL CO., LTD. (DOING BUSINESS AS YUNG SHIN PHARMACEUTICALS AND YUNG SHIN PHARM. IND. CO. LTD.), YUNG ZIP CHEMICAL CO., LTD., FANG-YU LEE, AND CHE-MING TENG, Defendants,
and CARLSBAD TECHNOLOGY, INC., Defendant-Appellant,
and FISH AND RICHARDSON P.C., AND Y. ROCKY TSAO, Defendants.

__________________________
2006-1522

__________________________HIF BIO v. YUNG SHIN PHARMA 2

Appeals from the United States District Court for the Central District of Califor nia in case no. 05-CV-07976, Judge Dean D. Pregerson.

ON PETITION FOR REHEARING

__________________________ Before M ICHEL , Chief Judge
, * G AJARSA , Circuit Judge
, and H OLDERMAN , Chief District Judge

. **
ORDER Defendant-Appellant Carlsbad Technology, Inc. filed a combined petition for panel rehearing and rehearing en banc. The petition for panel rehearing was considered by the panel that heard the appeal. The panel grants the petition for panel rehearing for the limited purpose of amending page 16, lines 12-18 of the issued opinion. Accordingly,
I T I S O RDERED T HAT : (1) The petition for panel rehearing is granted for the limited purpose of amending the following language on page 16, lines 12-18 of the issued opinion:
Because the second and fourth causes of action arise under § 1338(a), the district co urt abused its discretion in remanding those causes of action the First Amended Complaint to state court. See Hunter Douglas, Inc. , 153 F.3d at 1328; Baker , 387 F.3d at 656-57. However, on remand the district court should dismiss both the second and fourth causes of action under Rule 12(b)(6) because

* Paul R. Michel retired from the position of Chief Judge on May 31, 2010.

** The Honorable James F. Holderman, Chief Judge, United States District Court for the Northern District of Illinois, sitting by designation.HIF BIO v. YUNG SHIN PHARMA 3

plaintiffs have failed to state a claim upon which relief can be granted. Pursuant to 28 U.S.C. § 1367(c), the district court has discretion to decide on remand whether to exercise supplemental jurisdiction over the remaining causes of action. Additionally, because the r e maining state law c laims do not arise under federal law, the district should remand them to Califo r nia state court. (2) The petition for panel rehearing is otherwise denied.

F OR T HE C OURT

June 14, 2010

—————————— Date /s/ Jan Horbaly

—————————— Jan Horbaly Clerk

cc: Bub-Joo S. Lee, Esq. Glenn W. Rhodes, Esq.
#### Freddie FLETCHER, Plaintiff-Appellant, v. Sir Arthur GILBERT, Deceased, sued as the Arthur and Rosalind Gilbert 1982 Trust; et al., Defendants-Appellees.

No. 06-56825.

United States Court of Appeals, Ninth Circuit.

Submitted Dec. 20, 2007.*

Filed Dec. 28, 2007.

Freddie Fletcher, Los Angeles, CA, pro se.

Before: GOODWIN, WALLACE, and HAWKINS, Circuit Judges.

*

 The panel unanimously finds this case suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Freddie Fletcher, an attorney, appeals pro se from the district court’s judgment dismissing for lack of subject matter jurisdiction his action under 42 U.S.C. § 1983 challenging on constitutional grounds a final judgment rendered against him by the California Supreme Court. We have jurisdiction under 28 U.S.C. § 1291. We review de novo a district court’s jurisdictional dismissal based on the *Rooker-Feldman*doctrine. *Noel v. Hall,*341 F.3d 1148, 1154 (9th Cir.2003). We affirm.

Fletcher contends that the *Rooker-Feldman*doctrine should not apply because the state court lacked subject matter jurisdiction and rendered a void judgment. We disagree. *See Doe v. Mann,*415 F.3d 1038, 1043 n. 6 (9th Cir.2005) *(“Rooker-Feldman*applies where the plaintiff in federal court claims that the state court did not have jurisdiction to render a judgment.”). The district court properly concluded that the *Rooker-Feldman*doctrine barred Fletcher’s action because it is a “forbidden de facto appeal from a judicial decision of a state court,” and raises constitutional claims that are “inextricably intertwined” with that prior state court decision. *Noel,*341 F.3d. at 1158.

AFFIRMED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
Exhibit 32





CERTIFICATION





In
connection with the quarterly report of Franklin Covey Co. (the “Company”) on
Form 10-Q for the quarterly period ended November 29, 2008, as filed with the
Securities and Exchange Commission (the “Report”), we, Robert A. Whitman,
Chairman and Chief Executive Officer of the Company, and Stephen D. Young, Chief
Financial Officer of the Company, hereby certify as of the date hereof, solely
for purposes of Title 18, Chapter 63, Section 1350 of the United States Code,
that to the best of our knowledge:





1.
            The
      Report fully complies with the requirements of Section 13(a) or 15(d), as
      applicable, of the Securities Exchange Act of 1934, and2.
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the Company
      at the dates and for the periods
indicated.





This
Certification has not been, and shall not be deemed, “filed” with the Securities
and Exchange Commission.









/s/Robert A. Whitman
                      
                      /s/Stephen D. YoungRobert
      A. Whitman
                        Chief
      Executive Officer
                      
                      Stephen
      D. Young
                        Chief
      Financial OfficerDate:
      January 13, 2009
                      
                      Date:
      January 13,
2009
#### FIDELITY FINANCIAL SERVICES, INC., petitioner, v. Richard V. FINK, Trustee.

No. 96-1370.

Supreme Court of the United States.

May 12, 1997.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit granted.
<PAGE>   1

                                                                    EXHIBIT 15.1



                     INDEPENDENT ACCOUNTANTS' REVIEW REPORT

The Board of Directors and Shareholders
Collaborative Clinical Research, Inc.


We have reviewed the accompanying condensed consolidated balance sheet of
Collaborative Clinical Research, Inc. and subsidiaries (the "Company") as of
September 30, 1998, and the related condensed consolidated statements of
operations for the three-month and nine-month periods ended September 30, 1997
and 1998, and the condensed consolidated statements of cash flows for the
nine-month periods ended September 30, 1997 and 1998. These financial statements
are the responsibility of the Company's management.

We conducted our reviews in accordance with standards established by the
American Institute of Certified Public Accountants. A review of interim
financial information consists principally of applying analytical review
procedures to financial data, and making inquiries of persons responsible for
financial and accounting matters. It is substantially less in scope than an
audit conducted in accordance with generally accepted auditing standards, which
will be performed for the full year with the objective of expressing an opinion
regarding the financial statements taken as a whole. Accordingly, we do not
express such an opinion.

Based on our reviews, we are not aware of any material modifications that should
be made to the accompanying condensed consolidated financial statements referred
to above for them to be in conformity with generally accepted accounting
principles.

We have previously audited, in accordance with generally accepted auditing
standards, the consolidated balance sheet of Collaborative Clinical Research,
Inc. and subsidiaries as of December 31, 1997, and the related consolidated
statements of operations, shareholders' equity and cash flows for the year then
ended, not presented herein, and in our report dated January 30, 1998, we
expressed an unqualified opinion on those consolidated financial statements. In
our opinion, the information set forth in the accompanying condensed
consolidated balance sheet as of December 31, 1997 is fairly stated, in all
material respects, in relation to the consolidated balance sheet from which it
has been derived.

Cleveland, Ohio                                     ERNST & YOUNG LLP
October 19, 1998
Exhibit 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Quarterly Report of First Ipswich Bancorp (the
"Company") on Form 10-QSB for the quarter ended September 30, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Donald P. Gill, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

      (1)   The Report fully complies with the requirements of Section 13(a) or
            15(d) of the Securities Exchange Act of 1934; and

      (2)   The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company.

      This certification is provided solely pursuant to 18 U.S.C. Section 1350
and Item 601(b)(32) of Regulation S-K ("Item 601(b)(32)") promulgated under the
Securities Act of 1933 (the "Securities Act") and the Securities Exchange Act of
1934 (the "Exchange Act"). In accordance with clause (ii) of Item 601(b)(32),
this certification (A) shall not be deemed "filed" for purposes of Section 18 of
the Exchange Act, or otherwise subject to the liability of that section, and (B)
shall not be deemed to be incorporated by reference into any filing under the
Securities Act or the Exchange Act, except to the extent that the Company
specifically incorporates it by reference.


/s/ Donald P. Gill
------------------
Donald P. Gill
Chief Executive Officer

July 22, 2005
Exhibit 35.2



LOGO

ANNUAL STATEMENT OF COMPLIANCE

OF

LNR PARTNERS, LLC

The undersigned, Job Warshaw, being the President of LNR Partners, LLC (the Special Servicer), as special servicer under the
applicable Pooling and Servicing Agreement for the transactions listed on Schedule I hereto, hereby certifies, subject to any limitations listed on Schedule I hereto, as of the date hereof, on behalf of the Special Servicer, solely in
his capacity as an authorized officer of the Special Servicer and not in his individual capacity, as follows:



| | 1. | A review of the activities performed by the Special Servicer during the period commencing on January 1, 2014 and ending on December 31, 2014 (or any other shorter period set forth on Schedule I hereto)
(the Reporting Period), and of the Special Servicers performance under the Pooling and Servicing Agreement has been made under my supervision; and
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | To the best of my knowledge, based on such review and using the applicable servicing criteria under Item 1122 of Regulation AB, the Special Servicer has fulfilled all of its obligations under the applicable Pooling
and Servicing Agreement in all material respects throughout the Reporting Period.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



LNR PARTNERS, LLC,a Florida limited liability companyBy:

/s/ Job WarshawJob WarshawPresident


Dated: February 23, 2015





1601 Washington Avenue  Suite
700                            Miami Beach, Florida 33139-3164

Telephone: (305) 695-5600  Fax: (305) 695-5601



---

Schedule I

CGCMT 2013-GCJ11

Citigroup Commercial Mortgage Securities
Inc., Commercial Mortgage Pass-Through Certificates, Series 2013-GCJ11

Citibank, N.A.,

Global Transaction Services

388 Greenwich Street, 14th Floor

New York NY 10013

John Hannon

Citigroup Commercial Mortgage Securities Inc.

388 Greenwich
Street, 11 th Floor

New York NY 10013

Angela Vleck

Citigroup Commercial Mortgage Securities Inc.

390 Greenwich
Street, 5th Floor

New York NY 10013

Paul Vanderslice

Citigroup Commercial Mortgage Securities Inc.

388 Greenwich
Street, 19th Floor

New York NY 10013

Richard Simpson

Citigroup Commercial Mortgage Securities Inc.

388 Greenwich
Street, 17th Floor

New York NY 10013

Ryan M. OConnor

Pentalpha Surveillance LLC

375 N. French Road, Suite 100

Amherst NY 14228

Don Simon
# Fourth Court of Appeals

**San Antonio, Texas**

JUDG MENT

N o. 04

- 17

- 00025

- CV

FE EXPRESS, LLC and Francisco Javier Bernal, Appellants

v.

Maria Isabel Serna CONTRERAS , as next friend and guardian of Samara Isabella Morales

Serna and Samantha Isabel Morales Serna, minor children, and as Administrator of the Estate of Samuel Morales Castillo, Deceased, Appellees

From the 341st Judicial District Court, Webb County, Texas

Trial Court No. 2014CVT001295 D3 Honorable Rebecca Ramirez Palomo, Judge Presidin g

BEFORE CHIEF JUSTICE MARION

, JUSTICE CHAPA , AND JUSTICE RIOS

In accordance with this court’s opinion of this date, the trial court’s judgment is VACATED without regard to the merits and this case is REMANDED to the trial court with

instructions to vac ate the trial court’s July 17, 2017 Order Setting Amount of Security for Money Judgment and to release FE Express and its surety from the Supersedeas Bond filed on February
3, 2017. C osts of this appeal are assessed against appellant s

.

SIGNED January 17, 2018.

_________________________________ Luz Elena D. Chapa , Justice
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of State

          - [Public Notice 10103]

By virtue of the authority vested in me as the Secretary of State, including pursuant to section 7045(a)(4)(A) of the Department of State, Foreign Operations, and Related Programs Appropriations Act, 2017 (Div. J, Pub. L. 115-31), I hereby certify that the central government of Honduras is taking effective steps, which are in addition to those steps taken since the certification and report submitted during the prior year, to:
    - Inform its citizens of the dangers of the journey to the southwest border of the United States;
    - Combat human smuggling and trafficking;
    - Improve border security, including to prevent illegal migration, human smuggling and trafficking, and trafficking of illicit drugs and other contraband; and
    - Cooperate with United States Government agencies and other governments in the region to facilitate the return, repatriation, and reintegration of illegal migrants arriving at the southwest border of the United States who do not qualify for asylum, consistent with international law.

                    This certification shall be published in the                     **Federal Register**                     and, along with the accompanying Memorandum of Justification, shall be reported to Congress.                

Dated: August 22, 2017.

Rex W. Tillerson,

Secretary of State.

[FR Doc. 2017-18304 Filed 8-28-17; 8:45 am]

 BILLING CODE 4710-29-P
EXHIBIT 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002


I, Edward L. Machulak, Chairman, President, Treasurer, Chief Executive,
Operating and Financial Officer of Commerce Group Corp., (the "Company"),
hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.   the annual report on Form 10-K of the Company for the fiscal year
     ended March 31, 2006, filed on the date hereof with the Securities
     and Exchange Commission (the "Report"), fully complies with the
     requirements of Section 13(a) or 15(d) of the Securities Exchange
     Act of 1934; and

2.   the information contained in the Report fairly presents, in all
     material respects, the financial condition and results of operations
     of the Company.

Date:  June 27, 2006                     /s/ Edward L. Machulak
                                        -------------------------------
                                        Edward L. Machulak
                                        Chairman, President, Treasurer,
                                        Chief Executive, Operating and
                                        Financial Officer